TECHNOLOGY SUMMARY

The invention relates to compositions comprising IGFBP-3 receptor agonist monoclonal antibodies and methods for the treatment of cancers, metabolic syndrome, obstructive respiratory disorders and related diseases with IGFBP-3 receptor agonist monoclonal antibodies.

AREA/MATURITY/AWARDS

Primary Application Area: Medical Devices & Materials

Technology Development Status: Ready to Market

Technology Readiness Level: TRL 5

SHOWCASE SUMMARY

Organization Type: Academic/Gov Lab

Website: https://vcu.edu/

MARKET KEYWORDS

Market Keywords: cancer, metabolic syndrome, obstructive respiratory disorders